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Malignant melanoma of the conjunctiva is an 
extremely rare extraocular neoplasm. Local 
recurrence and metastases of this malignancy 
have been well documented in the literature,1,2 
but there does not seem to be any information 
regarding cases of paraneoplastic polyarthritis 
arising from this metastatic malignancy. Herein, 
we describe the case of a patient with palindromic 
rheumatism (PR)-like migratory non-erosive 
seronegative polyarthritis in conjunction with 
metastatic conjunctival malignant melanoma.
A 51-year-old female patient was admitted to 
our clinic with a three-year history of transient 
and recurrent pain and swelling in her left upper 
extremity. She had been diagnosed with left 
conjunctival malignant melanoma with multiple 
metastases. She started to feel pain and swelling 
in her left shoulder that radiated to all of the joints 
in her left upper extremity in the form of migratory 
and transient recurrent attacks. At times, these 
symptoms would subside completely without any 
residual disability, but they would then begin 
again in other joints of the same extremity. The 
symptoms always developed quickly and reached 
their peak within a few days. She had variable 
symptom-free intervals between the attacks which 
coincided with her history of pain and swelling.
Her physical examination revealed active 
arthritis in her upper extremity joints. Laboratory 
tests found an erythrocyte sedimentation rate 
of 84 mm/h and a C-reactive protein level of 
38.8 mg/L, but her rheumatoid factor serum and 
anti-cyclic citrullinated peptide antibody levels 
were within normal limits. The plain radiographs 
were normal.
She was prescribed non-steroidal anti-
inflammatory drugs, prednisone 5 mg/per day, 
oral methotrexate 7.5 mg/per week, and folinic 
acid 5 mg/per week. At the first follow-up 
appointment, patient’s attacks had resolved 
completely with these medications.
Palindromic rheumatism is an uncommon 
condition characterized by irregular, recurrent 
episodes of mostly oligoarticular arthritis with 
peri- and para-articular tissue inflammation that 
can last from a few hours to several days with 
variable symptom-free intervals. It leaves no 
residual clinical and radiographic changes, and 
between attacks, the joints are completely normal 
and asymptomatic. Because no distinct clinical, 
laboratory, or radiological markers have been 
identified, a diagnosis of PR is currently based on 
clinical features and the exclusion of other forms 
of episodic arthritis.3-8 Laboratory tests should 
also show an elevated erythrocyte sedimentation 
rate and a higher number of acute phase reactants 
during the attacks, with these remaining at 
normal levels between the attacks.4,6,9 Our patient 
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was consistent with the features mentioned 
above. Therefore, she was diagnosed with PR-like 
migratory non-erosive polyarthritis. Moreover, 
anti-cyclic citrullinated peptide antibodies are 
found in a high proportion of patients with 
PR,8 but our patient tested negative for these. 
Nevertheless, a negative result cannot eliminate 
the possibility of PR. Many wide-ranging 
treatment modalities exist for PR, but to date, no 
consensus exists regarding which is the best.8,10 
We prescribed non-steroidal anti-inflammatory 
drugs, prednisone, and methotrexate to our 
patient, and during the follow-up period, she 
reported that she experienced a remission of her 
arthritic attacks as a by-product of using these 
drugs.
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